Dr. Scott Kasner has formally retired from Penn to assume a new role as Neuroscience Clinical Development Lead at Bayer. In this new role, Dr. Kasner will be responsible for developing a global portfolio of potential new neurologic treatments. Dr. Kasner is now an Emeritus professor at Penn. While he will be greatly missed, we are happy to report he will continue to reside in Philadelphia and remain involved in the Stroke division as a trusted advisor and mentor.